Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Warren Gasper
Headshot of Warren Gasper
Warren Gasper

Description

Summary

This is a study to assess the safety and effectiveness of endovascular treatment of aortic aneurysms involving the proximal aortic arch. The investigational operation involves placing a stent-graft over the aortic aneurysm.

Official Title

Branched Stent-Graft Repair for Endo Repair of Aneurysms Involving the Proximal Aortic Arch

Details

An aneurysm is a localized bulge in the wall of an artery. Aneurysms of the aorta are prone to progressive dilatation, which if left untreated ultimately results in rupture, internal bleeding and death. Traditional open surgery involves aortic exposure through a long incision, aortic clamping to interrupt blood flow, and replacement or repair of the dilated aortic segment using a fabric conduit (graft), which is sutured (anastomosis) to the nondilated arteries above and below the aneurysm. Some subjects are able to withstand such a large operation better than others, but many suffer complications, and all suffer pain, debility, and a lengthy stay in hospital.

Endovascular aneurysm repair is a less invasive alternative that substitutes a trans-arterial route to the aneurysm for direct exposure, and stent-mediated attachment for sutured anastomosis. Compared to open surgical repair, endovascular repair is associated with less physiological derangement, less pain, less blood loss, lower complication rates and shorter hospital stay. Consequently, endovascular repair has become standard therapy for aneurysms of the abdominal aorta and descending thoracic aorta, where there are no vital branches and endovascular exclusion rarely causes ischemic complications.

Open surgical repair of the proximal aortic arch requires hypothermic circulatory arrest, because it deprives the heart of its outflow and the brain of its inflow. Endovascular repair also obstructs outflow from the heart, but only for a few seconds, while the graft is released from its delivery sheath. The greater problem is inflow to the brain. In anticipation of aortic arch exclusion, the brachiocephalic circulation requires an alternative source of blood. One alternative is bypass from the ascending aorta. However, this requires median sternotomy and partial aortic clamping, both of with are potential sources of morbidity.

Keywords

Aortic Aneurysm of the Proximal Arch, Aneurysm, Aortic Arch, Endovascular, Stent-Graft, Aortic Aneurysm, Endovascular Bifurcated Stent-Graft

Eligibility

You can join if…

Open to people ages 18 years and up

  • Aneurysm of the aortic arch larger than 6cm in diameter, or symptomatic aneurysm of the aortic arch, of any diameter, or any arch aneurysm with a 2-year rupture rate estimated to be more than 20%.
  • Anticipated mortality rate with open repair estimated to be more than 20%.
  • Suitable arterial anatomy for stent-graft
  • Life expectancy more than 2 years
  • Ability to give informed consent and willingness to comply with follow-up schedule

You CAN'T join if...

  • Free rupture of the aneurysm
  • Pregnancy
  • Anaphylactic reaction to contrast material
  • Allergy to stainless steel or polyester
  • Unwillingness or inability to comply with the follow-up schedule
  • Serious systemic or groin infection
  • Uncorrectable coagulopathy
  • Significant presence of carotid artery atherosclerosis
  • Arrhythmia define as 2nd- and 3rd-degree atrioventricular block or sinus node disease, such as sick sinus syndrome and symptomatic bradycardia, unless the patient already has a pacemaker in place and cardiology consultation confirms that it is safe to proceed.

Location

  • UCSF Division of Vascular and Endovascular Surgery accepting new patients
    San Francisco California 94143 United States

Lead Scientist at UCSF

  • Warren Gasper
    My current research interests fall broadly into the categories of vein / vein graft physiology and advanced endovascular aneurysm therapies.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Timothy Chuter, MD
ID
NCT00488696
Study Type
Interventional
Participants
Expecting 25 study participants
Last Updated